Hemoglobin Glycation Detection via Correlation Matrices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current non-invasive glucose monitoring techniques are inadequate for clinical use, as they are either invasive or lack accuracy and reliability, and existing optical methods for detecting glucose and other biological agents in human tissue have not been completely satisfactory.

Innovation Solution

A system and method using correlation matrices and orbital angular momentum signatures to detect glycation levels in hemoglobin, involving the generation of correlation matrices from light beams passing through a hemoglobin sample and subsequent singular value decomposition to identify a unique biomarker for glycation levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If non-invasive optical methods are used for glucose monitoring, then patient comfort and safety are improved, but measurement accuracy and reliability deteriorate

Engineering Contradiction:
ImproveinvasivenessVSAvoidglucose detection accuracy
Core Design Contradiction:
Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The patent transitions from conventional single-wavelength or simple spectral analysis to multi-dimensional spectral analysis using correlation matrices. By analyzing light absorption across multiple wavelengths simultaneously and constructing correlation matrices from spectral data at different wavelengths, the system extracts more information from the optical signal, thereby improving measurement accuracy while maintaining non-invasive operation.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent changes the parameter of analysis from simple intensity measurement to correlation-based spectral analysis. By computing correlation coefficients between spectral features at different wavelengths and using these correlations to detect glycation levels, the system enhances the sensitivity and specificity of glucose monitoring without requiring invasive sampling.

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If conventional spectroscopy methods are used, then device complexity is reduced, but the ability to detect glycation and distinguish biochemical states deteriorates

Engineering Contradiction:
Improvesystem simplicityVSAvoidglycation detection capability
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent segments the spectral analysis process into distinct computational stages: acquiring spectra at multiple wavelengths, constructing correlation matrices from these spectra, performing singular value decomposition on the correlation matrices, and extracting glycation-specific biomarkers. This segmentation allows the system to process complex multi-wavelength data systematically, improving glycation detection while keeping the device architecture manageable through modular signal processing.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces correlation matrices as an intermediary computational structure between the raw spectral data and the final glycation measurement. The correlation matrices serve as a mediator that captures the relationships between spectral features at different wavelengths, enabling the system to distinguish glycation states more effectively than direct spectral analysis while adding only moderate computational complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If multi-wavelength correlation matrix analysis is implemented, then glycation detection accuracy is improved, but computational complexity and processing time increase

Engineering Contradiction:
Improveglycation level accuracyVSAvoidcomputational processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent performs preliminary computation by pre-calculating correlation matrices from the multi-wavelength spectral data before conducting singular value decomposition. This preliminary organization of data into correlation structures simplifies the subsequent decomposition step and enables more efficient extraction of glycation biomarkers, reducing overall computational burden while maintaining high measurement accuracy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts only the essential information from the complex correlation matrices through singular value decomposition, identifying and isolating the specific biomarkers related to glycation. By taking out only the relevant components from the full spectral correlation analysis, the system achieves accurate glycation detection while minimizing unnecessary computational processing.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables non-invasive detection of glycation levels in hemoglobin, providing a reliable and accurate method for monitoring glucose and other biological agents within human tissue, potentially improving diabetes management and other metabolic disease diagnostics.

Implementation Method 1

A first correlation matrix is generated using a first light beam at a first wavelength passing through a hemoglobin sample. A second correlation matrix is generated using a second light beam at a second wavelength passing through the hemoglobin sample.

Methodology Applied
Scientific EffectAbsorption spectroscopy: Absorption Spectroscopy

Data Source

PatentUS10209192B2Spectroscopy with correlation matrices, ratios and glycation
Publication Date: 2019.02.19 NXGEN PARTNERS IP LLC
  • US10209192B2 patent drawing
  • US10209192B2 patent drawing
  • US10209192B2 patent drawing

AI summary

A system and method for detecting glycation levels within hemoglobin generates a first correlation matrix using a first light beam at a first wavelength passing through a hemoglobin sample. A second correlation matrix is generated using a second light beam at a second wavelength passing through the hemoglobin sample. The first correlation matrix is multiplied by an inverse of the second correlation matrix to obtain a third matrix. A fourth matrix is generated by taking a singular value decomposition of the third matrix. The fourth matrix comprises a unique biomarker for a level of glycation within the hemoglobin sample. The level of glycation within the hemoglobin sample is determined responsive to the fourth matrix and an indicator identifying the determined level of glycation is output.